We are part of the CSL Limited group of companies. See how we're Driven by Our Promise.
We collaborate with rare disease organizations to promote quality medical care and services.
We offer a variety of support programs and activities for the patients we serve.
We also aim to make sure that nothing holds you back from getting the therapies you need.
Our product portfolio focuses on innovation in new products, improved products and manufacturing expertise.
A clinical trial is a research study that is done to find out if medical treatments can improve people’s health.
We work every day as if someone’s life depends on it, because it does.
We manufacture products to treat a number of rare diseases.
Help us deliver on our promise to save lives and protect the health of people.
Diversity and inclusion are top priorities for CSL Behring.
Stay Safe With "Sharps"
An expert nurse offers advice for patients who self-infuse medicines at home.
A Harris Poll of Hereditary Angioedema Patients
A recent survey shed light on how this rare disease affects daily life and what they value most.
HAE and Kids
Hereditary angioedema, a challenging rare disease to manage, causes serious swelling episodes. Children can have them, too.
HAE + COVID-19
A patient who has HAE, which causes dangerous swelling, shares his experience with a COVID-19 infection.
10 Things to Know About Monoclonal Antibodies
CSL Behring made three recent announcements related to medicines known as “mabs.”
COVID-19 and Hereditary Angioedema
Experts respond to questions from HAE community about virus’ effect on rare swelling condition.
3 Lessons from a Patient Who Faced Her Dragon
Born with a rare, genetic disease, an HAE patient shared her story with CSL Behring staff in Kankakee, Illinois
A Wallet-Sized Way to Ensure the Right Care
HAE International’s emergency cards help physicians provide the right care in critical moments.
Video: Raising Kids and Managing a Rare Disease
Our patients share what it’s like to be a parent living with a rare condition.
Growing in Germany to Meet Demand
Biotech CSL Behring unveils expansion plans in Marburg.
Forty Years of Knowing How
Replacing C1-INH plasma protein gives a rare disease a longed-for treatment.
Video: How to Tell Teachers About a Rare Disease
One mom's tips for ensuring a child's condition is managed in the classroom.
Popular search terms:
Americas
Asia Pacific
Europe
This website uses cookies to improve user experience. By continuing to use this website, you consent to our use of these cookies. To learn more about how we use and manage cookies, see our Privacy Policy and Cookie Policy.
